MedNavigate LLC is hosting a hands-on webinar on September 16 to help evaluate the robustness of clinical trial design across all stakeholders.

MedNavigate LLC is a health economics, market access, and commercialization consultancy serving emerging and mid-cap biotechnology, medical device, diagnostic, and healthcare technology companies. We work alongside client teams to develop the evidence, reimbursement strategies, and payer-ready value stories needed to bring innovative products to market successfully. Led by Dr. Nancy Hedlund, PhD, MBA, MedNavigate and its network of experienced collaborators help life sciences companies navigate the path from product development to successful market access and commercialization. We partner with organizations that have promising innovations but need a clear, evidence-based strategy to address the practical realities of coding, coverage, payment, payer expectations, and adoption within health systems. Our services include developing evidence strategies; assessing market, coding, coverage, and payment pathways; designing payer-relevant clinical and real-world evidence plans; quantifying clinical and economic value; preparing reimbursement and payer communication materials; and aligning cross-functional teams around a credible commercialization roadmap. MedNavigate is especially valuable for companies seeking senior-level strategic guidance and flexible, fractional support without the cost or commitment of a full-time executive hire.